Cyclosporine Combined with Levamisole for Lower-Risk Myelodysplastic Syndromes

Publisher： Karger

E-ISSN： 1421-9662|134|3|138-145

ISSN： 0001-5792

Source： Acta Haematologica, Vol.134, Iss.3, 2015-04, pp. : 138-145

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Comparing the prognostic value of risk stratifying models for patients with lower‐risk myelodysplastic syndromes: Is one model better?

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 90, Iss. 11, 2015-11 ,pp. : 1036-1040

John Wiley & Sons Inc

Access to resources Recommend Favorite

Validation of the revised international prognostic scoring system (IPSS‐R) in patients with lower‐risk myelodysplastic syndromes: a report from the prospective European LeukaemiaNet MDS (EUMDS) registry

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 170, Iss. 3, 2015-08 ,pp. : 372-383

John Wiley & Sons Inc

Access to resources Recommend Favorite

New Aspects of the Treatment of Patients with Low-Risk Myelodysplastic Syndromes

By  

Oncology Research and Treatment, Vol. 23, Iss. 1, 2000-03 ,pp. : 12-16

Karger

Access to resources Recommend Favorite

Myelodysplastic syndromes: 2015 Update on diagnosis, risk‐stratification and management

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 90, Iss. 9, 2015-09 ,pp. : 831-841

John Wiley & Sons Inc

Access to resources Recommend Favorite

Decitabine in myelodysplastic syndromes

By Jabbour Elias   Kantarjian Hagop M   Garcia-Manero Guillermo   Issa Jean-Pierre J  

Therapy, Vol. 2, Iss. 6, 2005-11 ,pp. : 835-842

Future Medicine

Access to resources Recommend Favorite